<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Following central <z:mp ids='MP_0008912'>nervous</z:mp> system insults, control of intracranial pressure may lessen the incidence of morbidity and mortality </plain></SENT>
<SENT sid="1" pm="."><plain>Therapies to control intracranial pressure include osmolar agents, prevention of and control of <z:hpo ids='HP_0001250'>seizures</z:hpo>, drainage of cerebrospinal fluid, <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, and <z:chebi fb="25" ids="22693">barbiturates</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Control of <z:hpo ids='HP_0000713'>agitation</z:hpo> and excessive patient movement are additional components in the management of ICP </plain></SENT>
<SENT sid="3" pm="."><plain>Although opioids and <z:chebi fb="13" ids="22720">benzodiazepines</z:chebi> are generally effective, in a small subset of patients, alternative agents may be necessary </plain></SENT>
<SENT sid="4" pm="."><plain>The authors present 2 children with increased ICP in whom <z:chebi fb="3" ids="44915">propofol</z:chebi> was used to provide sedation and control ICP </plain></SENT>
<SENT sid="5" pm="."><plain>The use of <z:chebi fb="3" ids="44915">propofol</z:chebi> in this setting and its possible applications in the children with increased ICP are discussed </plain></SENT>
</text></document>